People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dova Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $10.0M | $309.7M | 2016 |
John A. Stalfort at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John A. Stalfort on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul B. Manning | 1 | 6 |
| James C. Reebals | 1 | 2 |
| Russell T. Schundler | 1 | 1 |
| Hossein T. Ekrami | 1 | 1 |
| Eugene R. Scavola | 1 | 1 |
| Damian R. deGoa | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.